Journal article
The expanding role of co-trimoxazole in developing countries.
- Abstract:
-
Co-trimoxazole is an inexpensive, broad-spectrum antimicrobial drug that is widely used in developing countries. Before antiretroviral therapy (ART) scale-up, co-trimoxazole prophylaxis reduced morbidity and mortality in adults and children with HIV by preventing bacterial infections, diarrhoea, malaria, and Pneumocystis jirovecii pneumonia, despite high levels of microbial resistance. Co-trimoxazole prophylaxis reduces early mortality by 58% (95% CI 39-71) in adults starting ART. Co-trimoxaz...
Expand abstract
Actions
Authors
Bibliographic Details
- Journal:
- Lancet. Infectious diseases
- Publication date:
- 2014-11-01
- DOI:
- EISSN:
-
1474-4457
- ISSN:
-
1473-3099
- Source identifiers:
-
492070
Item Description
- Language:
- English
- Pubs id:
-
pubs:492070
- UUID:
-
uuid:a09e4d25-e8b8-44ab-9599-22967aafe57e
- Local pid:
- pubs:492070
- Deposit date:
- 2014-12-15
Terms of use
- Copyright date:
- 2014
If you are the owner of this record, you can report an update to it here: Report update to this record